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Introduction & Objectives
• Intralesional triamcinolone is the most common 
treatment, but has side effects and recurrence is high1
• Surgical excision is also commonly used and can be 
necessary for quality of life
– But has high rates of recurrence2
• Keloid: a benign skin lesion 
representing overgrowth of collagen 
as an aberrant response to injury
– Symptoms include pain, pruritis, & 
infections
– Etiology is largely unknown, which is 






– How does intralesional triamcinolone (ILK) 
monotherapy compare with surgical excision in 
reducing size and ameliorating symptoms in patients 
with keloids treated at Thomas Jefferson University 
Hospital?
• Hypothesis
– Patients with keloids treated with intralesional 
triamcinolone (ILK) will have greater reduction in size 
and greater improvement in symptoms compared to 
patients treated surgically.
Approach
• Study design 
– Retrospective medical chart review and phone survey
• Population / study sample
– Patients with keloids treated at Jefferson, spanning from 2015 to 2020
• Intervention 
– Intralesional triamcinolone injection
• Comparison group 
– Surgical excision of keloid
• Outcome 
– Change in size, change in symptoms (pruritus and pain)
• Data source and collection
– Database comprised of Jefferson patients with keloids treated in the past 5 years 
– Data will be collected from Epic medical charts and patients themselves via phone survey
• Analysis






• Surgical excision was more effective than ILK in reducing overall size 
and patient symptoms of pain and pruritis.
– Previous studies have demonstrated surgical excision followed by ILK or 
cryotherapy to be effective at diminishing keloid size.2, 4
• When broken down by location, the greatest difference in 
treatment outcome regarding symptom reduction was seen in ear 
keloids.
– Fits with current literature that treatment outcomes vary based on 
anatomical location4
• Implication: surgical excision followed by adjuvant treatment may 
be the most effective treatment at long term removal of keloids and 
prevention of symptom recurrence.
– Yet, strong claims cannot be made at this time due to the sample size 
limitations of the study.
Future Directions
• Gather more data on patients treated with surgical excision to 
make the sample size more robust and make a stronger 
comparison
• Compare treatment outcomes of those treated with surgical 
excision plus varying types of adjuvant therapy (cryotherapy, 
ILK, 5-FU)
• Study the varying effects of ILK vs. excision on auricular 
keloids to gain a better understanding of outcome variance 
based on anatomical location
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